TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,861 | -38.8% | 21,691 | 0.0% | 0.00% | – |
| Q2 2023 | $6,312 | -84.6% | 21,691 | 0.0% | 0.00% | – |
| Q1 2023 | $40,996 | +58.7% | 21,691 | +25.1% | 0.00% | – |
| Q4 2022 | $25,832 | -10.9% | 17,337 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -17.1% | 17,337 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -23.9% | 17,337 | 0.0% | 0.00% | – |
| Q1 2022 | $46,000 | -4.2% | 17,337 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -28.4% | 17,337 | 0.0% | 0.00% | – |
| Q3 2021 | $67,000 | -40.7% | 17,337 | 0.0% | 0.00% | – |
| Q2 2021 | $113,000 | – | 17,337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |